I Wodinsky

1.2k total citations
69 papers, 979 citations indexed

About

I Wodinsky is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, I Wodinsky has authored 69 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Organic Chemistry. Recurrent topics in I Wodinsky's work include Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (11 papers) and Biochemical and Molecular Research (8 papers). I Wodinsky is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (11 papers) and Biochemical and Molecular Research (8 papers). I Wodinsky collaborates with scholars based in United States. I Wodinsky's co-authors include David Kessel, Thomas C. Hall, Charles J. Kensler, Jacob J. Clement, John M. Venditti, Randall K. Johnson, Raphael Catane, D W Yesair, Ruth I. Geran and Awtar Krishan and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

I Wodinsky

62 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Wodinsky United States 15 492 331 100 97 90 69 979
A Goldin United States 19 478 1.0× 454 1.4× 157 1.6× 149 1.5× 126 1.4× 114 1.3k
W R Laster United States 17 397 0.8× 317 1.0× 175 1.8× 129 1.3× 100 1.1× 42 957
Laster Wr United States 18 433 0.9× 574 1.7× 92 0.9× 125 1.3× 242 2.7× 28 1.2k
I Kline United States 17 242 0.5× 266 0.8× 65 0.7× 75 0.8× 81 0.9× 60 702
Montgomery Ja United States 11 282 0.6× 234 0.7× 73 0.7× 89 0.9× 86 1.0× 18 685
J.R. Bertino United States 16 462 0.9× 221 0.7× 69 0.7× 52 0.5× 75 0.8× 28 925
R G Moran United States 18 878 1.8× 352 1.1× 122 1.2× 136 1.4× 120 1.3× 28 1.3k
T J Fraser United States 8 424 0.9× 207 0.6× 58 0.6× 63 0.6× 33 0.4× 9 686
G L Neil United States 19 548 1.1× 169 0.5× 190 1.9× 74 0.8× 36 0.4× 42 867
K.R. Harrap United Kingdom 18 574 1.2× 523 1.6× 219 2.2× 81 0.8× 119 1.3× 31 1.2k

Countries citing papers authored by I Wodinsky

Since Specialization
Citations

This map shows the geographic impact of I Wodinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Wodinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Wodinsky more than expected).

Fields of papers citing papers by I Wodinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Wodinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Wodinsky. The network helps show where I Wodinsky may publish in the future.

Co-authorship network of co-authors of I Wodinsky

This figure shows the co-authorship network connecting the top 25 collaborators of I Wodinsky. A scholar is included among the top collaborators of I Wodinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Wodinsky. I Wodinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wodinsky, I, et al.. (1979). Enhanced activity against murine tumors of cyclophos- phamide in combination with the hypoxic cell radiosen- sitizer, misonidazole. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 3 indexed citations
2.
Wodinsky, I, et al.. (1979). Combined therapy with an aziridine derivative NSC 200724 (AB182) and radiation on an experimental leukemia. International Journal of Radiation Oncology*Biology*Physics. 5(9). 1677–1680. 5 indexed citations
3.
Wodinsky, I, et al.. (1978). Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(7). 1025–32. 4 indexed citations
4.
5.
Wodinsky, I, et al.. (1977). 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.. PubMed. 37(6). 1692–6. 14 indexed citations
6.
Wodinsky, I, et al.. (1976). Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors.. PubMed. 59(5). 939–50. 14 indexed citations
7.
Wodinsky, I, et al.. (1972). Metabolism of daunomycin (NSC-82151) in vitro and the chemotherapeutic activity of isolated metabolites in vivo.. PubMed. 56(3). 315–20. 7 indexed citations
8.
Kessel, David & I Wodinsky. (1970). Thymidine Kinase as a Determinant of the Response to 5-Fluoro-2'-deoxyuridine in Transplantable Murine Leukemias. Molecular Pharmacology. 6(3). 251–254. 12 indexed citations
9.
Wodinsky, I, et al.. (1969). Metabolic basis for enhanced chemotherapy of solid l1210 with 6-mp. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 74. 1 indexed citations
10.
Kessel, David, et al.. (1969). Accumulation of two alkylating agents, nitrogen mustard and busulfan, by murine leukemia cells in vitro. Biochemical Pharmacology. 18(5). 1229–1234. 9 indexed citations
11.
Kessel, David, et al.. (1968). Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.. PubMed. 28(5). 938–41. 130 indexed citations
12.
Wodinsky, I, et al.. (1968). On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.. PubMed. 28(10). 1955–62. 24 indexed citations
13.
Yesair, D W, et al.. (1967). Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells.. PubMed. 27(2). 314–21. 9 indexed citations
14.
Kessel, David, Thomas C. Hall, & I Wodinsky. (1966). Nucleotide Formation as a Determinant of 5-Fluorouracil Response in Mouse Leukemias. Science. 154(3751). 911–913. 4 indexed citations
15.
Wodinsky, I & Charles J. Kensler. (1966). Growth of L1210 Leukaemia Cells. Nature. 210(5039). 962–962. 2 indexed citations
16.
Wodinsky, I, et al.. (1965). Studies on folic reductase. 3. The level of enzyme activity and response to methotrexate of transplantable mouse tumors.. PubMed. 25(11). 1899–903. 27 indexed citations
17.
Yesair, D W, et al.. (1964). Intracellular localization and effects of 2-chloro-4', 4''-di(2- -imidazolin-2-yl)terephthalanilide (nsc 60339) in liver, kidney and p388 leukemia. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 54. 4 indexed citations
18.
Leiter, Joseph, et al.. (1963). SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XIV.. PubMed. 23. SUPPL1278–473. 1 indexed citations
19.
Kelly, Margaret G., et al.. (1957). STRAIN DIFFERENCES IN LOCAL HEMORRHAGIC RESPONSE (SHWARTZMAN-LIKE REACTION) OF MICE TO A SINGLE INTRADERMAL INJECTION OF BACTERIAL POLYSACCHARIDES. The Journal of Experimental Medicine. 105(6). 653–664. 9 indexed citations
20.
Wodinsky, I, et al.. (1955). LOCALIZATION OF PROTEIN-BOUND I131IN THE THYROID GLAND OF THE MOUSE. Endocrinology. 56(1). 9–20. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Goldin Breakdown of academic impact, for papers by W R Laster Breakdown of academic impact, for papers by Laster Wr Breakdown of academic impact, for papers by I Kline Breakdown of academic impact, for papers by Montgomery Ja Breakdown of academic impact, for papers by J.R. Bertino Breakdown of academic impact, for papers by R G Moran Breakdown of academic impact, for papers by T J Fraser Breakdown of academic impact, for papers by G L Neil Breakdown of academic impact, for papers by K.R. Harrap
Rankless by CCL
2026